Skip to main content
. 2017 May 12;8:839. doi: 10.3389/fmicb.2017.00839

Figure 1.

Figure 1

Time-dependent killing assay of stationary-phase (A) and logarithmic phase (B) wild-type PAO1 and the ΔrpoN, ΔrpoS, ΔrpoNΔrpoS, and ΔrpoN/rpoN+ mutants treated with 32 μg/ml tobramycin grown in LB. Wild-type PAO1 was grown without tobramycin and served as a growth control. Percent survival at the indicated time points was calculated by dividing the number of CFU/ml after antibiotic treatment by the CFU/ml before addition of tobramycin. The experiment was performed in triplicate. Error bars indicate SDs. P ≤ 0.05 (*), ≤0.01 (**), or ≤0.001(***) vs. wild type.